Literature DB >> 12176734

Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice.

Karl Rouger1, Martine Le Cunff, Marja Steenman, Marie-Claude Potier, Nathalie Gibelin, Claude A Dechesne, Jean J Leger.   

Abstract

The mdx mouse is a model for human Duchenne muscular dystrophy (DMD), an X-linked degenerative disease of skeletal muscle tissue characterized by the absence of the dystrophin protein. The mdx mice display a much milder phenotype than DMD patients. After the first week of life when all mdx muscles evolve like muscles of young DMD patients, mdx hindlimb muscles substantially compensate for the lack of dystrophin, whereas mdx diaphragm muscle becomes progressively affected by the disease. We used cDNA microarrays to compare the expression profile of 1,082 genes, previously selected by a subtractive method, in control and mdx hindlimb and diaphragm muscles at 12 time points over the first year of the mouse life. We determined that 1) the dystrophin gene defect induced marked expression remodeling of 112 genes encoding proteins implicated in diverse muscle cell functions and 2) two-thirds of the observed transcriptomal anomalies differed between adult mdx hindlimb and diaphragm muscles. Our results showed that neither mdx diaphram muscle nor mdx hindlimb muscles evolve entirely like the human DMD muscles. This finding should be taken under consideration for the interpretation of future experiments using mdx mice as a model for therapeutic assays.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176734     DOI: 10.1152/ajpcell.00112.2002

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  24 in total

1.  Skeletal muscle repair in a mouse model of nemaline myopathy.

Authors:  Despina Sanoudou; Mark A Corbett; Mei Han; Majid Ghoddusi; Mai-Anh T Nguyen; Nicole Vlahovich; Edna C Hardeman; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2006-07-28       Impact factor: 6.150

2.  mRNA expression characteristics are different in irreversibly atrophic intrinsic muscles of the forepaw compared with reversibly atrophic biceps in a rat model of obstetric brachial plexus palsy (OBPP).

Authors:  Ji-Xin Wu; Liang Chen; Fei Ding; Le-Zi Chen; Yu-Dong Gu
Journal:  J Muscle Res Cell Motil       Date:  2016-02-22       Impact factor: 2.698

3.  Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.

Authors:  Judith N Haslett; Despina Sanoudou; Alvin T Kho; Richard R Bennett; Steven A Greenberg; Isaac S Kohane; Alan H Beggs; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

4.  Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.

Authors:  Stefano Gambardella; Fabrizio Rinaldi; Saverio M Lepore; Antonella Viola; Emanuele Loro; Corrado Angelini; Lodovica Vergani; Giuseppe Novelli; Annalisa Botta
Journal:  J Transl Med       Date:  2010-05-20       Impact factor: 5.531

5.  Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization.

Authors:  Mohammad M Ghahramani Seno; Capucine Trollet; Takis Athanasopoulos; Ian R Graham; Pingzhao Hu; George Dickson
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

6.  Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.

Authors:  Christopher F Spurney; Hee-Jae Cha; Arpana Sali; Gouri S Pandey; Emidio Pistilli; Alfredo D Guerron; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

7.  Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.

Authors:  Yuki Nakayama; Noriko Nara; Yukiko Kawakita; Yasuhiro Takeshima; Masayuki Arakawa; Masaki Katoh; Sumiyo Morita; Ken Iwatsuki; Kiyoko Tanaka; Shiki Okamoto; Toshio Kitamura; Naohiko Seki; Ryoichi Matsuda; Masafumi Matsuo; Kayoko Saito; Takahiko Hara
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 8.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

9.  Gene expression profiling of Duchenne muscular dystrophy skeletal muscle.

Authors:  Judith N Haslett; Despina Sanoudou; Alvin T Kho; Mei Han; Richard R Bennett; Isaac S Kohane; Alan H Beggs; Louis M Kunkel
Journal:  Neurogenetics       Date:  2003-04-16       Impact factor: 2.660

10.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.